LENZ Therapeutics Inc.
LENZ | NASDAQ
$4.08
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.08
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:29 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.48M | 20.99M | 19.09M | 17.5M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.12M | 1.86M | 705K | 180K | 55K | 36K | n/a | n/a | n/a | n/a | n/a | n/a | 2.17M | 4.23M | 6.12M | 6.12M | 4.51M | 2.55M | 746K | 867K | 311K | 212K |
Gross Profit | 19.36M | 19.13M | 18.38M | 17.32M | 4.95M | -36K | n/a | n/a | n/a | n/a | n/a | n/a | -2.17M | -4.23M | -6.12M | -6.12M | -4.51M | -2.55M | -746K | -867K | -311K | -212K |
Operating Income | -135.66M | -118.34M | -91.14M | -67.9M | -61.96M | -59.45M | -58.61M | -68.37M | -75.29M | -75.9M | -72.43M | -56.57M | -62.86M | -74.67M | -88.02M | -97.83M | -86.28M | -77.03M | -60.44M | -49.83M | -38.99M | -22.75M |
Interest Income | 10.1M | 10.08M | 9.76M | 9.34M | 9.87M | 10.09M | 8.55M | 5.99M | 4.34M | 2.13M | 1.34M | 1.34M | 1.72M | 1.47M | 1.47M | 1.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -126M | -108.49M | -81.63M | -58.38M | -51.9M | -47.74M | -49.77M | -60.99M | -69.65M | -74.13M | -70.15M | -55.4M | -61.2M | -73.14M | -86.61M | -96.42M | -86.33M | -77.2M | -70.76M | -115.37M | -104.16M | -87.94M |
Net Income | -126M | -109M | -82.13M | -58.88M | -52.4M | -47.74M | -49.77M | -60.81M | -69.47M | -73.95M | -69.97M | -55.71M | -61.51M | -73.44M | -86.92M | -96.42M | -86.33M | -77.2M | -70.76M | -115.37M | -104.16M | -87.94M |
Selling & General & Admin | 151.22M | 124.62M | 90.85M | 60.68M | 39.71M | 34.34M | 28.81M | 24.91M | 21.27M | 16.19M | 12.93M | 8.97M | 13.96M | 18.58M | 22.1M | 28.34M | 25.85M | 23.68M | 21.77M | 15.84M | 11.93M | 8.04M |
Research & Development | 3.79M | 12.85M | 18.67M | 24.54M | 27.2M | 25.08M | 29.8M | 43.47M | 54.02M | 59.72M | 59.5M | 47.6M | 46.73M | 51.87M | 59.79M | 63.36M | 55.91M | 50.8M | 37.93M | 33.12M | 26.74M | 14.5M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 155.02M | 137.48M | 109.52M | 85.22M | 66.9M | 59.42M | 58.61M | 68.37M | 75.29M | 75.9M | 72.43M | 56.57M | 60.69M | 70.44M | 81.89M | 91.7M | 81.76M | 74.49M | 59.7M | 48.96M | 38.68M | 22.54M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 157.13M | 139.33M | 110.23M | 85.4M | 66.96M | 59.45M | 58.61M | 68.37M | 75.29M | 75.9M | 72.43M | 56.57M | 62.86M | 74.67M | 88.02M | 97.83M | 86.28M | 77.03M | 60.44M | 49.83M | 38.99M | 22.75M |
Income Tax Expense | 5K | 502K | 502K | 501K | 501K | 1K | 1K | -179K | -179K | -179K | -179K | 303K | 303K | 303K | 303K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 31.37M | 31.35M | 31.07M | 28.54M | 28.08M | 27.53M | 27.49M | 27.17M | 25.61M | 4.72M | 8.29M | 8.18M | 8.11M | 7.98M | 7.96M | 7.89M | 7.8M | 7.72M | 8.29M | 8.3M | 8M | 8.3M |
Shares Outstanding (Diluted) | 31.37M | 31.35M | 31.07M | 28.54M | 28.08M | 27.53M | 27.49M | 27.17M | 25.61M | 4.72M | 8.29M | 8.18M | 8.11M | 7.98M | 7.96M | 7.89M | 7.8M | 7.72M | 8.29M | 8.3M | 8M | 8.3M |
EPS (Basic) | -4.09 | -3.60 | -2.81 | -2.11 | -1.90 | -1.77 | -4.77 | -7.08 | -9.45 | -15.87 | -15.34 | -15.66 | -16.04 | -12.64 | -13.03 | -12.22 | -10.85 | -9.62 | -8.61 | -13.99 | -12.64 | -10.61 |
EPS (Diluted) | -4.09 | -3.60 | -2.81 | -2.11 | -1.90 | -1.77 | -4.77 | -7.08 | -9.45 | -15.87 | -15.34 | -15.66 | -16.04 | -12.64 | -13.03 | -12.22 | -10.85 | -9.62 | -8.61 | -13.99 | -12.64 | -10.61 |
EBITDA | -125.54M | -108.13M | -81.34M | -58.18M | -51.81M | -47.65M | -49.71M | -60.95M | -69.62M | -74.11M | -70.13M | -55.39M | -59.03M | -68.9M | -80.49M | -90.29M | -81.81M | -74.65M | -70.01M | -114.5M | -103.47M | -87.33M |
EBIT | -126M | -108.49M | -81.63M | -58.38M | -51.9M | -47.74M | -49.77M | -60.99M | -69.65M | -74.13M | -70.15M | -55.4M | -61.2M | -73.14M | -86.61M | -96.42M | -86.33M | -77.2M | -70.76M | -115.37M | -104.16M | -87.92M |
Depreciation & Amortization | 453K | 362K | 287K | 205K | 90K | 89K | 58K | 37K | 31K | 17K | 15K | 14K | 2.18M | 4.24M | 6.13M | 6.12M | 4.51M | 2.55M | 746K | 867K | 691K | 592K |
Add to Watchlist
Select watchlists to add or remove LENZ